Corporate news 22 Apr, 2021NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors
New services & innovation 10 Jun, 2021Academic and industrial cooperation: the road to innovative drug discovery technologies
Corporate news 18 May, 2021NovAliX expands cryo-electron microscopy (cryo-EM) capabilities for drug development offering
Events 18 Mar, 2021Exciting program and speakers for the 2nd NovAliX Conference “Biophysics in Drug Discovery”
Corporate news 26 Jan, 2021NovAliX partners with Chemical.AI to develop artificial intelligence toolkit for drug discovery
Events 18 Nov, 2020Large audience at a dynamic first virtual NovAliX Conference “Biophysics in Drug Discovery”
27 May, 2021C(sp3)–H methylation enabled by peroxide photosensitization and Ni-mediated radical coupling
30 Apr, 2021Remarkably Efficient Iridium Catalysts for Directed C(sp2)–H and C(sp3)–H Borylation of Diverse Classes of Substrates
21 Apr, 2021Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology
